Brand-name vs generic
Clinical reviewer: Jacob Moore, MD · Last checked September 16, 2026
What is the difference between brand-name and generic drugs?
Brand-name vs generic refers to two ways the same active ingredient can reach the market: under a manufacturer's trademarked name, or, once patents and exclusivity expire, as an FDA-approved generic. FDA requires generics to match the brand drug's ingredient, strength, form and route.
What has to match between a brand-name and a generic drug?
FDA requires an approved generic to contain the same active ingredient as the brand-name, or innovator, drug, at the same strength, in the same dosage form, such as a tablet or an injectable, and given by the same route of administration, such as oral or topical [1]. FDA states that approved generic medicines "work in the same way and provide the same clinical benefit and risks" as their brand-name counterparts [1]. A generic drug that meets FDA's scientific standards can generally receive final approval once the brand drug's patents and marketing exclusivities expire, or if those patents are successfully challenged [1].
How is a compounded drug different from a generic?
A generic drug goes through FDA's approval process and must establish therapeutic equivalence to the brand-name drug before reaching patients [2]. A compounded drug, prepared by a pharmacy for an individual patient, is not approved by FDA through that process [2]. That difference matters for GLP-1 medications: see compounded semaglutide and wegovy generic name for how it applies to specific drugs.
Related terms
Sources
This entry is for education and is not medical advice. Talk with a licensed clinician about your own situation before starting, stopping, or changing any treatment.
